Division of Cardiology, Nippon Medical School Chiba-Hokusoh Hospital, Chiba, Japan.
J Cardiol. 2012 Sep;60(3):180-6. doi: 10.1016/j.jjcc.2012.03.003. Epub 2012 Apr 21.
Sleep disordered breathing (SDB) is highly prevalent in patients with cardiovascular disease, although it is not clear whether SDB has any link to coronary atherosclerotic burden in patients with stable coronary artery disease (CAD). This study sought to analyze the links between SDB, coronary atherosclerotic burden, and cardiac biomarkers in stable CAD patients.
We studied 83 consecutive patients who underwent coronary angiography or scheduled percutaneous coronary intervention. SDB was evaluated by an ambulatory polysomnographic monitoring device. Coronary atherosclerotic burden was evaluated by the Gensini score, and myocardial stress/injury were assessed by measuring plasma levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP) and high sensitivity troponin T (hs-TnT). Patients with an apnea hypopnea index (AHI)≧15 events/h (n=32) showed significantly higher Gensini score (35.7±38.0 vs 20.1±19.7, p=0.033) than those with AHI<15. The higher AHI group showed significantly higher NT-proBNP (275.8±402.6 pg/ml vs 131.9±146.3 pg/ml, p=0.047) and hs-TnT levels (0.011±0.005 ng/ml vs 0.008±0.003 ng/ml, p=0.015). Furthermore it was revealed that AHI significantly correlated with the Gensini score (r=0.253, p=0.036), NT-proBNP (r=0.266, p=0.027), and hs-TnT (r=0.274, p=0.023), and multiple stepwise linear regression analysis revealed that AHI (β=0.257, p=0.029) and history of smoking (β=0.244, p=0.038) were independently correlated with Gensini score among clinical and SDB-related parameters.
Severity of SDB has a significant link to the severity of coronary atherosclerotic burden, which also reflected elevated NT-proBNP and hs-TnT as silent myocardial ischemia and minute myocardial injury even in stable CAD patients.
睡眠呼吸障碍(SDB)在心血管疾病患者中非常普遍,尽管尚不清楚 SDB 是否与稳定型冠状动脉疾病(CAD)患者的冠状动脉粥样硬化负担有关。本研究旨在分析 SDB、冠状动脉粥样硬化负担和稳定型 CAD 患者心脏生物标志物之间的关系。
我们研究了 83 例连续接受冠状动脉造影或计划行经皮冠状动脉介入治疗的患者。通过动态多导睡眠监测仪评估 SDB。冠状动脉粥样硬化负担用 Gensini 评分评估,通过测量 N 末端 pro-B 型利钠肽(NT-proBNP)和高敏肌钙蛋白 T(hs-TnT)的血浆水平评估心肌应激/损伤。呼吸暂停低通气指数(AHI)≧15 次/小时的患者(n=32)的 Gensini 评分明显高于 AHI<15 的患者(35.7±38.0 vs 20.1±19.7,p=0.033)。AHI 较高组的 NT-proBNP(275.8±402.6 pg/ml vs 131.9±146.3 pg/ml,p=0.047)和 hs-TnT 水平(0.011±0.005 ng/ml vs 0.008±0.003 ng/ml,p=0.015)明显更高。此外,研究还表明 AHI 与 Gensini 评分(r=0.253,p=0.036)、NT-proBNP(r=0.266,p=0.027)和 hs-TnT(r=0.274,p=0.023)显著相关,多元逐步线性回归分析显示,在临床和 SDB 相关参数中,AHI(β=0.257,p=0.029)和吸烟史(β=0.244,p=0.038)与 Gensini 评分独立相关。
SDB 的严重程度与冠状动脉粥样硬化负担的严重程度有显著关系,即使在稳定型 CAD 患者中,也反映出 NT-proBNP 和 hs-TnT 升高,提示存在无症状性心肌缺血和微小心肌损伤。